Test Food4GutMarKIT - Evaluation of a Tailored Personalized Food Concept for a Healthy Gut Microbiota and Validation of Biomarkers for Monitoring of Its Effects
The overall test test test test aim in this "proof-of-concept" study is to evaluate if a diet concept, based on
foods that have individually been reported to beneficially affect gut microbiota in fact has
an effect on gut microbiota composition and activity among healthy and obese subjects and
whether the effects are associated with altered cardiometabolic risk factors. The aim is
further to investigate if such alterations are reflected in changes of the fecal and plasma
metabolome. In total, 40 men and women, who meet all the inclusion criteria and none of the
exclusion criteria will be invited to participate in the study. The participants will follow
an intervention diet for 6 weeks and a control diet for 6 weeks, with a 6-week wash-out
period in between and will be randomized to either begin with the intervention diet or the
control diet.
The study will be running over 18 weeks (including a 6-week wash-out period) and it will
include 9 visits at the clinic.
You can use content blocks to arrange your articles, large texts,
instructions. Combine these blocks with media blocks to add
illustrations and video tutorials. You can use various content blocks to
work with your text. Add quotations, lists, buttons. Select your text to
change its formatting or add links. You can use various content blocks
to work with your text. Add quotations, lists, buttons. Select your text
to change its formatting or add links.
Email
Download
Print
About the Clinical Trials
Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Duis viverra et felis vitae commodo. Duis ornare bibendum.
Feature One
Class aptent taciti ad litora torquent per conubia nostra, per inceptos himenaeos. Duis viverra et felis vitae.
Feature Two
Class aptent taciti ad litora torquent per conubia nostra, per inceptos himenaeos. Duis viverra et felis vitae.
Feature Three
Class aptent taciti ad litora torquent per conubia nostra, per inceptos himenaeos. Duis viverra et felis vitae.
Feature Four
Class aptent taciti ad litora torquent per conubia nostra, per inceptos himenaeos. Duis viverra et felis vitae.
Pursuing progress against advanced prostate cancer
Joining a clinical trial is an important and personal decision. Your doctor may have mentioned the TALAPRO-3 study, or perhaps you found your way here by yourself. To qualify for this study, you may not have received certain anti-cancer treatments, such as:
platinum-based chemotherapy within the past 5 years
a novel hormone therapy (NHT), such as enzalutamide, or abiraterone/prednisone, or apalutamide if taken for more than 3 months
a PARP inhibitor (PARPi)
androgen deprivation treatment for more than 3 months
Condition
metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Age
18+ years
Number of study visits
Upto 25
Length of study
About 3 years
Diabetes
What is Diabetes?
A large percentage of viewers are on mobile devices, so keep it short
and to the point. Have you ever noticed how long a 5 sentence
paragraph looks on a smart phone? If you read it via desktop/laptop,
you realize it is really not that much information. A suggestion is to
plan on “marrying” the two and keep the chatter down. Conversely,
don’t sacrifice the “meat and potatoes” of what you’re trying to
convey; this will help to keep the organic SEO strong.
What causes Diabetes?
Viewers need to be given a direction every now and then. Use your
headers to draw the eye where you want it. Imagine the website as a
term paper and your outline will guide your structure. Focus broad
topics on the main headers and help guide the viewer down the right
path! Appropriately introducing call-to-action buttons also helps with
guiding the reader and connecting content writing with your website’s
goal.
How is Diabetes treated?
Here are a few website content writing tips to make sure your website
content gets the attention it deserves • Know your audience • Write
short, simple sentences – Nix the jargon – Mix up your word choice •
Make text scannable • Incorporate multimedia Capturing reader’s
interests with good website content and information can be
challenging. Most visitors will spend just a few seconds on a webpage,
before deciding what to do next. Therefore, good website writing is
the key to beating these odds.
More information about Diabetes
National Diabetes Foundation National Diabetes Foundation – Support
Network American Academy of Diabetes International Diabetes Council
International Federation of Diabetes Associations
Call
1800-9860-568
now to find out if you are eligible.
Are you a patient with moderate to severe plaque psoriasis?
Have you treated your condition with adalimumab (Humira®) and did it
become less effective on your plaque psoriasis within the last 6 months?
If so, you may be eligible for a clinical research study with etanercept
(Enbrel®) which is also approved for moderate to severe plaque
psoriasis. Qualified participants will receive an initial consultation,
study-related examinations, and study medication.
Are you a patient with moderate to severe plaque psoriasis?
Have you treated your condition with adalimumab (Humira®) and did it
become less effective on your plaque psoriasis within the last 6 months?
If so, you may be eligible for a clinical research study with etanercept
(Enbrel®) which is also approved for moderate to severe plaque
psoriasis. Qualified participants will receive an initial consultation,
study-related examinations, and study medication.
Diabetes
A short sentence to introduce what to expect in the about condition
section
Are you a patient with moderate to severe plaque psoriasis?
Have you treated your condition with adalimumab (Humira®) and did it
become less effective on your plaque psoriasis within the last 6 months?
If so, you may be eligible for a clinical research study with etanercept
(Enbrel®) which is also approved for moderate to severe plaque
psoriasis. Qualified participants will receive an initial consultation,
study-related examinations, and study medication.
Are you a patient with moderate to severe plaque psoriasis?
Have you treated your condition with adalimumab (Humira®) and did it
become less effective on your plaque psoriasis within the last 6 months?
If so, you may be eligible for a clinical research study with etanercept
(Enbrel®) which is also approved for moderate to severe plaque
psoriasis. Qualified participants will receive an initial consultation,
study-related examinations, and study medication.
Take up this questionnaire to help us determine if you have symptoms
that are common to this clinical study. If you have the common
symptoms, you may be eligible to take part in the study.
Preview complete
The prescreener preview is complete. You may now close the preview.